ARAriel Roitman

Ariel Roitman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ariel Roitman has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Seth H. Dailey

    Department of Otolaryngology‐Head and Neck Surgery, School of Medicine and Public Health University of Wisconsin‐Madison Madison Wisconsin USA

    5 shared publications
  • Kristopher M. Schroeder

    Department of Anesthesiology University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA

    3 shared publications
  • Susan L. Thibeault

    Department of Otolaryngology‐Head and Neck Surgery, School of Medicine and Public Health University of Wisconsin‐Madison Madison Wisconsin USA

    3 shared publications
  • Andrew J. Bowen

    Department of Otolaryngology‐Head and Neck Surgery, School of Medicine and Public Health University of Wisconsin‐Madison Madison Wisconsin USA

    2 shared publications
  • Anumitha Venkatraman

    Department of Surgery, University of Wisconsin–Madison

    2 shared publications
  • Ilana Doweck

    Department of Otolaryngology - Head and Neck Surgery, Carmel Medical Center, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel

    2 shared publications

Latest Publications

  • Three-Year Oncologic Outcomes of 445-nm TruBlue Laser Ablation for Early Glottic Cancer and Dysplasia

    by Hadar Gez Reder, Yotam Aharon Shiner, Itamar Shenfeld, Ilana Doweck, Ariel Roitman

  • Open Access

    Revisiting Fire Safety Guidelines in CO 2 Laser Airway Surgery

    by Ariel Roitman, Seth H. Dailey, Marcus Wilson, Andrew J. Bowen, Kristopher M. Schroeder, Susan L. Thibeault

    Introduction: The potential for airway fire during endoscopic laser surgery is well known, typically addressed by reducing FiO 2 levels. This study revisits these established practices in CO 2 laser tubeless airway surgery. Materials and Methods: Using a cadaveric porcine larynx and lung model, we conducted trials with high‐flow (HFV) and jet ventilation. We varied FiO 2 levels and laser power settings to record the onset and number of brief, expansive, and blowtorch flames. Results: Flames were observed in all jet ventilation trials. Multivariable model results showed that increasing laser wattage decreased onset times for expansive/blowtorch flames and increased their frequency ( p < 0.05). Increased FiO 2 changes were not significant ( p > 0.05). HFV trials revealed no expansive flames at 4 W at 100%, 6 W at 70%, and 10 W at 50% FiO 2 . Increasing wattage shortened flame onset and increased frequency across all flames ( p < 0.01), while increasing FiO 2 only reduced onset time for brief flames ( p < 0.05). Jet ventilation led to higher flame incidence and shorter onset times than HFV ( p < 0.05). Conclusion: Fire risk during CO 2 laser surgery in oxygen‐rich environments is influenced more by wattage, rather than FiO 2 levels. Jet ventilation consistently produced expansive flames, even at lower FiO 2 levels and wattage, supporting a FiO 2 limit of 30% for this ventilation technique. Our findings support HFV as a potentially safer option for CO 2 laser surgery, with safe zones of 4 W at 100%, 6 W at 70%, and 10 W at 50% FiO 2 , provided laser application is under 30 s. Our model's calculation of excess risk from wattage increments can help surgeons assess this fire risk.


  • Open Access

    Redefining Safe Practices in Airway TruBlue Laser Surgery—A Systematic Evaluation

    by Ariel Roitman, Marcus Wilson, Andrew J. Bowen, Kristopher M. Schroeder, Susan L. Thibeault, Seth H. Dailey

    Objectives: Fire risk during laser airway surgery is well‐documented, but there is limited information regarding this risk with the novel TruBlue laser. This study evaluates its safety under different experimental conditions. Methods: Using a cadaveric porcine larynx and lungs model, we conducted trials with laser‐safe endotracheal tubes (LSETTs), high‐flow ventilation (HFV), and jet ventilation. We varied distance, FiO 2 levels, and laser power settings to observe the occurrence of uncontrolled fires, brief flames, and sparks. Results: LSETT trials showed no fire events. Pledget fires were the only uncontrolled fires in HFV, at 100%, 70%, and 50% FiO 2 . Brief flames occurred only with 4 W continuous settings at 100% FiO 2 . Innocuous spark ignition rates were significantly increased by increased wattage ( p < 0.05). In jet ventilation trials, brief flames appeared across a wider range of FiO 2 levels and settings. HFV and jet ventilation groups showed a greater frequency and earlier occurrence of sparks and brief flames, in contrast to the event‐free LSETT group ( p < 0.05). Conclusion: Using the TruBlue laser with a fully inflated LSETT cuff positioned at least 0.3 cm below the operating area while delivering 100% oxygen was consistently safe in our trials. Uncontrolled fires occurred only when targeting a pledget under HFV, confirming extrinsic fuel as the main risk and highlighting the safety of the TruBlue laser with HFV and jet ventilation in its absence. Compared to HFV, jet ventilation trials showed a higher frequency of brief flames and sparks. A 60‐s continuous application of the laser at 100% FiO 2 is safe. Level of Evidence: NA.


  • Open Access

    How I Do IT: Making Awake Airway Examinations Safer, Cheaper, and Easily Accessible

    by Ariel Roitman, Liam Duffy, Seth H. Dailey

  • In Response to Does the TruBlue Laser Set Microlaryngoscopy Equipment on Fire?—A Systematic Evaluation

    by Ariel Roitman, Tadeas Lunga, Anumitha Venkatraman, Kristopher M. Schroeder, Susan L. Thibeault, Seth H. Dailey

  • Open Access

    Does the TruBlue Laser Set Microlaryngoscopy Equipment on Fire? A Systematic Evaluation

    by Ariel Roitman, Tadeas Lunga, Anumitha Venkatraman, Kristopher M Schroeder, Susan L Thibeault, Seth H Dailey

    Introduction: The risk of fire during laser microlaryngoscopy is well known. However, limited information is available about fire risk with the novel TruBlue laser. This study systematically evaluates its interactions with common surgical supplies, offering valuable insights into safety considerations for surgeons. Material and Methods: We used experimental conditions to test the extent to which TruBlue laser energy produces smoke, perforation, or fire in Rüsch®, Medtronic™ and microlaryngeal endotracheal tubes and in surgical pledgets. Results: Only the Microlaryngeal Tube (MLT) caught fire. Notably, it happened only when the laser fiber shifted on the tube's surface. Smoke emerged solely from the laser fiber applied to the Medtronic™ shaft and only during continuous contact mode. Cuff perforation and smoke emanating from the shaft occurred in three‐quarters of the Rüsch® trials. The pledgets' radiopaque segment exhibited a greater combustibility than other segments ( p < 0.01). In many of the pledget trials, faster smoke emission occurred with shorter laser‐to‐target distances ( p < 0.05). Water‐soaked pledgets displayed a reduced rate of smoke production ( p < 0.01) and string division. Conclusion: The Medtronic™ tube assures remarkable safety with a nonignitable shaft and low cuff ignition. The MLT poses the highest ignition risk. Cuff perforation risk is mitigated by maintaining a 0.3‐cm distance from the laser fiber tip. Pledget fire risk is mitigated by positioning the radiopaque part away from the laser beam and by soaking the pledget with water. Laser division of the pledgets' string was common. Level of Evidence: NA Laryngoscope , 135:1752–1758, 2025


  • Open Access

    Predictors of injection laryngoplasty volume for glottic insufficiency

    by Ariel Roitman, Anumitha Venkatraman, Susan Thibeault

    Purpose: Volume injected for glottic insufficiency is paramount in achieving desired outcome. Factors that determine the required volume have not been thoroughly investigated and may correlate with outcome. The first objective of this investigation was to evaluate the association between injectable volume and various parameters, including lifestyle characteristics, pre-procedural factors, and voice measures, while the second aim assessed the correlation of volume to clinical outcomes in patients who underwent injection laryngoplasty. Methods: For the first objective, a one-way ANOVA and univariate linear regression were used to analyze data from 124 patients (injected material, pre-operative diagnosis, previous voice therapy, age etc.). One-sample t-tests and Pearson correlational coefficients were employed for statistical analysis of aim 2 in a subgroup of 28 patients that had pre- and post-injection voice evaluations (e.g., acoustic and aerodynamic analysis, perceptual assessment, questionnaires). Results: Average injection volume was 0.39 ± 0.062 mL (range: 0.1–1.6mL). No pre-procedural or lifestyle factor significantly affected injection volume (p > 0.05). There was no relationship between pre-procedural voice outcomes and injection volume (p > 0.05). Of the factors that were significantly improved post-injection laryngoplasty (GFI, VHI, and GRBAS), there were no significant correlations between the magnitude of improvement in these measures and injection volume (p > 0.05). Conclusion: Injection volume does not appear to be affected by pre-procedural or lifestyle factors. In addition, injection volume does not significantly impact clinical outcomes assessed through voice analysis or patient-reported questionnaires. Our results underscore the complexity of factors at play in injection laryngoplasty for glottic insufficiency.

  • Open Access

    Laboratory and imaging findings of necrotizing otitis externa are associated with pathogen type and disease outcome: A retrospective analysis.

    by Itai Margulis, Raanan Cohen-Kerem, Ariel Roitman, Hadar Gez-Reder, Ariel Aviram, Sivan Bitterman-Fisher, Nir Kugelman, Ilana Doweck

    Objective: To examine associations of laboratory and imaging data with diagnostic parameters of necrotizing otitis externa (NOE) and its severity, and to compare between bacterial and fungal infections. Methods: Records of patients diagnosed with NOE during 2010–2018 at the Department of Otolaryngology, Head and Neck Surgery were reviewed retrospectively for demographics; disease characteristics; and laboratory, scintigraphy, and imaging results. Results: Of 48 patients with NOE, the mean age is 73±11.6 years; 32 (67%) were males; 83% had diabetes mellitus. Common pathogens were pseudomonas (49%) and fungi (33%). Sensitivities of the technetium-scan (SPECT ratio ≥1.5), temporal bone computed tomography (CT), and gallium-scan (SPECT ratio ≥1.3) were: 78.7%, 48.8%, and 31.4%, respectively. Gallium-scan results correlated positively with CT bone involvement (p=0.002) and hospital length of stay (p=0.0014). C-reactive protein (CRP) level correlated with hospital length of stay (p=0.028) and positive technetium-scan results (p=0.012). Fungal infection had a higher technetium SPECT ratio (2.16 vs. 1.77, p=0.04), gallium SPECT ratio (1.4 vs. 1.2, p=0.02), longer duration of systemic treatment (87.4 vs. 37.9 days, p=0.014), and longer hospital length of stay (31.6 vs. 15.2 days, p=0.004) compared to non-fungal infection. Eight (17%) patients had responded poorly to treatment. Fungal pathogens, facial nerve paresis, extra-auricular, and bilateral disease were more prevalent among the non-responders. Conclusion: The technetium scan has higher sensitivity than temporal bone CT for diagnosing NOE. The gallium scan and CRP correlated well with hospital length of stay. A high rate of fungal infection was found, with significantly higher technetium and gallium SPECT ratios and worse outcome compared to bacterial infection. Fungal NOE remains therapeutically challenging.